AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test.
about
GSK-3 Inhibitors: Preclinical and Clinical Focus on CNSLithium: the pharmacodynamic actions of the amazing ionRegulation of glycogen synthase kinase-3 during bipolar mania treatmentTherapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorderThe role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesisA new look at an old drug: neuroprotective effects and therapeutic potentials of lithium saltsFunctional Selectivity and Antidepressant Activity of Serotonin 1A Receptor LigandsReview of pharmacological treatment in mood disorders and future directions for drug development.Cell atrophy and loss in depression: reversal by antidepressant treatmentA role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental healthCellular plasticity cascades in the pathophysiology and treatment of bipolar disorderDopamine receptors - IUPHAR Review 13Lithium and bipolar mood disorder: the inositol-depletion hypothesis revisitedMolecular actions and clinical pharmacogenetics of lithium therapyDISC1: Structure, Function, and Therapeutic Potential for Major Mental IllnessLong-lasting antidepressant action of ketamine, but not glycogen synthase kinase-3 inhibitor SB216763, in the chronic mild stress model of miceCdk5 phosphorylates Cdh1 and modulates cyclin B1 stability in excitotoxicityBipolar disorder: candidate drug targets.Antipsychotic-like effects of a neurotensin receptor type 1 agonist.Deletion of GSK3β in D2R-expressing neurons reveals distinct roles for β-arrestin signaling in antipsychotic and lithium action.Examination of methylphenidate-mediated behavior regulation by glycogen synthase kinase-3 in mice.Sex differences in the activity of signalling pathways and expression of G-protein-coupled receptor kinases in the neonatal ventral hippocampal lesion model of schizophrenia.Glycogen synthase kinase-3 in the etiology and treatment of mood disorders.Is glycogen synthase kinase-3 a central modulator in mood regulation?The extracellular signal-regulated kinase pathway contributes to the control of behavioral excitementReverse translational strategies for developing animal models of bipolar disorder.Deficiency in the inhibitory serine-phosphorylation of glycogen synthase kinase-3 increases sensitivity to mood disturbances.Convergent functional genomic studies of ω-3 fatty acids in stress reactivity, bipolar disorder and alcoholism.Selective deletion of forebrain glycogen synthase kinase 3β reveals a central role in serotonin-sensitive anxiety and social behaviourTargeting protein kinases in central nervous system disordersPharmacological and toxicological effects of lithium in zebrafish.Gene expression analysis of novel genes in the prefrontal cortex of major depressive disorder subjects.Novel insights into lithium's mechanism of action: neurotrophic and neuroprotective effectsA kinesin signaling complex mediates the ability of GSK-3beta to affect mood-associated behaviors.Inhibition of GSK3 attenuates dopamine D1 receptor agonist-induced hyperactivity in miceRole of the axonal initial segment in psychiatric disorders: function, dysfunction, and interventionWnt2 expression and signaling is increased by different classes of antidepressant treatments.Potential mechanisms of action of lithium in bipolar disorder. Current understanding.Inflammation and lithium: clues to mechanisms contributing to suicide-linked traits.Novel drugs and therapeutic targets for severe mood disorders.
P2860
Q21129334-B1BC3948-796B-4CDB-AA82-9D68B45AAE70Q22241779-45AEB1AD-FD9E-4C64-BD40-D9980178E6B5Q24594534-64CD36AD-5AE6-4EDB-ADF0-3B7C9ECBCF8BQ24626017-E02EF4E0-2438-43E9-A0F1-9A27D4437EFAQ24651407-818AC754-4D3E-4BDF-AED0-FBC2B8FBA8A8Q26741164-12EFAD48-8E6E-46A1-8C4F-6CF36DD05923Q26799334-B734A0FD-4213-4D4F-9354-7D01838B8C3AQ26853509-4D4EEC2D-EE14-4CD3-9088-E860009BDC3AQ27013609-07BE977B-F48F-40D2-B8E4-56ECCA4C79EFQ28118906-878D5952-2BF6-4AC7-8103-4CBFC1DEF0E0Q28251880-61DA1FB3-2D32-4D2A-8240-C4BD9DE78F9DQ28256783-A37FF3B6-F363-4A58-BA00-C23B3459F90CQ28294604-A6856CB3-4B2D-4D7C-B488-BAE3225C93C8Q28307770-47545344-6D08-40E0-90D5-AE310AFF2ED3Q28393891-5E9AA6EC-56BE-41FA-97E2-A0CC8D12730FQ28485938-97966164-92E4-48F0-ACDC-67009C0CB6DBQ28580995-12AF04C2-31BE-4B95-A6C4-C2C8F7C61403Q28751133-F60B99AB-4110-499C-918A-E40CD28C644EQ30356261-E0BE0820-37CD-4A29-B639-D72CB48B54E7Q30453635-1799A163-31D8-4577-8B5A-299C5FE4285EQ30456006-9D1BAB57-8353-4681-A346-2D5BC38B25FFQ30470945-2200476F-E27E-4311-9504-C0A71E8A9398Q30474415-A1AA31F2-DDDE-4525-ABFF-03CD9AA4B087Q30475816-50ABB0AD-2CDC-4BE6-9456-495BA312D32AQ30484058-98D7CE17-1EDB-4296-8D9C-EF037087B3B3Q30489800-B2DE58C9-9A6F-4F83-BD87-35FA81B89076Q30495108-9E1E4419-73B1-40A3-93B7-5883B64D31DFQ30511829-B4BE9E95-3E21-4775-A948-10E246E1C3A4Q30522548-795C0968-EA8F-4CD6-824B-E981757EB83BQ33671660-69E339FA-2A95-44A1-8D10-CB7368CFDA5DQ33777992-355244DC-4D15-497A-8B1F-468249852D10Q33874356-0E13935E-946D-47AB-B0C4-F695C5BFBA57Q33929918-6E09E83B-33EF-4A66-90D6-8EDE13847139Q33953387-7D747969-FFBA-4188-AB38-20D6644DFE2EQ34001519-C8A12858-7B41-488F-BBF9-E6EF02CE0DA6Q34071914-51B4398C-89EB-404C-91F0-3A776636F686Q34088354-10652839-AC37-4DAE-B022-64250CDD0D57Q34325612-C2C90A17-5ED7-484A-A95F-1180A2A15DD8Q34731214-915C7CAC-50DA-491D-860C-C7A5EEE77373Q34732759-B00302EB-CFFA-4EBB-AA6C-F03D8AE9E698
P2860
AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
AR-A014418, a selective GSK-3 ...... fects in the forced swim test.
@en
AR-A014418, a selective GSK-3 ...... fects in the forced swim test.
@nl
type
label
AR-A014418, a selective GSK-3 ...... fects in the forced swim test.
@en
AR-A014418, a selective GSK-3 ...... fects in the forced swim test.
@nl
prefLabel
AR-A014418, a selective GSK-3 ...... fects in the forced swim test.
@en
AR-A014418, a selective GSK-3 ...... fects in the forced swim test.
@nl
P2093
P1476
AR-A014418, a selective GSK-3 ...... fects in the forced swim test.
@en
P2093
Haim Einat
Husseini K Manji
Ratan Bhat
Todd D Gould
P304
P356
10.1017/S1461145704004535
P577
2004-07-26T00:00:00Z